menu
    • menu

    Company profile for Vivos Therapeutics

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vivos offers a multidisciplinary treatment protocol that uses nonsurgical, noninvasive, and cost-effective oral appliance technology prescribed by trained dentists and medical professionals to treat dentofacial anomalies and/or mild to moderate OSA. This revolutionary treatment is called the Vivos Method. The Vivos Method is a customized treatment plan that begins with simple and easy at-home sleep apnea screening using our...
    Vivos offers a multidisciplinary treatment protocol that uses nonsurgical, noninvasive, and cost-effective oral appliance technology prescribed by trained dentists and medical professionals to treat dentofacial anomalies and/or mild to moderate OSA. This revolutionary treatment is called the Vivos Method. The Vivos Method is a customized treatment plan that begins with simple and easy at-home sleep apnea screening using our proprietary technology: VivoScore powered by SleepImage.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vivos TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9137 S Ridgeline Blvd Suite 135 Highlands Ranch, CO 80129
    Telephone
    Telephone
    (720) 399-9322
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://vivos.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vivos Therapeutics Reports Q1 2026 Results and Operational Update
    Vivos Therapeutics Reports Q1 2026 Results and Operational Update

    20 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/20/3298869/0/en/vivos-therapeutics-reports-first-quarter-2026-financial-results-and-provides-operational-update.html

    GLOBENEWSWIRE
    20 May 2026
    Share Share
    Vivos Therapeutics Reports Full Year 2025 Financial Results
    Vivos Therapeutics Reports Full Year 2025 Financial Results

    15 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/15/3274908/0/en/Vivos-Therapeutics-Reports-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    15 Apr 2026
    Share Share
    Vivos Therapeutics Schedules FY 2025 Results and Conference Call
    Vivos Therapeutics Schedules FY 2025 Results and Conference Call

    15 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/15/3274457/0/en/Vivos-Therapeutics-Schedules-Release-of-Full-Year-2025-Financial-Results-and-Conference-Call.html

    GLOBENEWSWIRE
    15 Apr 2026
    Share Share
    Vivos Completes Private Placement With New Seneca Partners
    Vivos Completes Private Placement With New Seneca Partners

    07 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/07/3269171/0/en/Vivos-Therapeutics-Completes-Private-Placement-with-Existing-Private-Equity-Investor-New-Seneca-Partners.html

    GLOBENEWSWIRE
    07 Apr 2026
    Share Share
    Vivos Practices Secure In-Network Status in Nevada
    Vivos Practices Secure In-Network Status in Nevada

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3263022/0/en/Vivos-Therapeutics-Reports-that-Supported-Professional-Practices-Have-Achieved-In-Network-Status-Across-Multiple-Commercial-Health-Insurers-and-Medicare-in-Key-Nevada-Market.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Vivos Expands Manufacturing With U.S. And Global Sites
    Vivos Expands Manufacturing With U.S. And Global Sites

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3239279/0/en/Vivos-Inc-Diversifies-Manufacturing-Base-with-Planned-U-S-and-International-Production-Sites.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search